Company profile: Aspect Biosystems
1.1 - Company Overview
Company description
- Provider of bioprinted tissue therapeutics via a full-stack platform combining bioprinting, therapeutic cells, biomaterials, and computational design to create implantable tissues. Products include pancreatic tissues to maintain normal glycemia in type 1 diabetes without immune suppression; liver tissues to restore function in acquired or genetic liver diseases; plus computational tissue design, cell/biomaterial processing, and manufacturing.
Products and services
- Full-Stack Tissue Therapeutic Platform: Integrates bioprinting technology, therapeutic cells, biomaterials, and computational design to engineer implantable tissues for treating diseases, creating biologically functional constructs (computationally designed)
- Liver Tissue Therapeutic: Bioprinted hepatic assemblies aimed at restoring lost or damaged liver function in patients with acquired or genetic liver diseases (implantable)
- Pancreatic Tissue Therapeutic: Bioprinted pancreatic tissues engineered to maintain normal glycemia in type 1 diabetes patients without the need for immune suppression (immune-suppression-free)
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Aspect Biosystems
Tinkerine
HQ: Canada
Website
- Description: Provider of 3D printing technologies and educational content, including the Ditto series 3D printers and Tinkerine U.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tinkerine company profile →
Adaptive3D
HQ: United States
Website
- Description: Provider of premium additive manufacturing polymer resins, partnering with global leaders to deliver solutions for functional end-use products and prototypes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adaptive3D company profile →
MakerBot
HQ: United States
Website
- Description: Provider of desktop 3D printing solutions, including MakerBot Sketch Series printers for education, MakerBot CloudPrint software, the Educator’s Guidebook, and the Thingiverse Education community. Offers MakerCare service plans and advanced UltiMaker S Series dual-extrusion 3D printers. A subsidiary of Stratasys with one of the largest desktop 3D printer install bases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MakerBot company profile →
AddiFab
HQ: Denmark
Website
- Description: Provider of Freeform Injection Molding systems and integrated solutions based on proprietary 3D printer systems, print resins and processes. Delivers a printing, injecting and dissolving process to create complex-geometry parts, supports a wide range of injection-moldable materials from soft rubbers to hard metals, and offers the Nexa3D XiP desktop resin 3D printer for rapid prototyping and production-grade components.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AddiFab company profile →
Additive Orthopaedics
HQ: United States
Website
- Description: Provider of 3D-printed orthopedic devices and implants for the extremities, including custom corrective foot implants, designed for faster manufacturing and to improve the chances of successful correction.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Additive Orthopaedics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Aspect Biosystems
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Aspect Biosystems
2.2 - Growth funds investing in similar companies to Aspect Biosystems
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Aspect Biosystems
4.2 - Public trading comparable groups for Aspect Biosystems
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →